KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $5.0 billion.

  • Bristol Myers Squibb's Long-Term Deferred Tax rose 3746.19% to $5.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 3746.19%. This contributed to the annual value of $4.2 billion for FY2024, which is 5303.47% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Long-Term Deferred Tax stood at $5.0 billion for Q3 2025, which was up 3746.19% from $4.6 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Long-Term Deferred Tax ranged from a high of $5.0 billion in Q3 2025 and a low of $650.0 million during Q2 2021
  • Its 5-year average for Long-Term Deferred Tax is $2.3 billion, with a median of $1.5 billion in 2023.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first crashed by 4025.74% in 2021, then soared by 13837.52% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Long-Term Deferred Tax (Quarter) stood at $1.4 billion in 2021, then dropped by 6.6% to $1.3 billion in 2022, then surged by 105.95% to $2.8 billion in 2023, then surged by 53.03% to $4.2 billion in 2024, then increased by 17.12% to $5.0 billion in 2025.
  • Its last three reported values are $5.0 billion in Q3 2025, $4.6 billion for Q2 2025, and $4.0 billion during Q1 2025.